TrialCancer immunity2010
Blockade of cytotoxic T-lymphocyte antigen-4 by ipilimumab results in dysregulation of gastrointestinal immunity in patients with advanced melanoma.
David Berman et al.PubMed ↗Full text ↗
No numbers read from the abstract.
109 papers cite itlatest 60 shown
this paperpooled ittrialcites it